In vitro/ex vivo liver models for the prediction of idiosyncratic drug-induced liver injury
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Hannover, Tierärztliche Hochschule Hannover, Dissertation, 2017
- Schlagwort
-
Biopharmazie
Pharmakodynamik
Pharmakokinetik
- Ereignis
-
Veröffentlichung
- (wo)
-
Hannover
- (wer)
-
Bibliothek der Tierärztlichen Hochschule Hannover
- (wann)
-
2017
- Urheber
-
Granitzny, Anne
- URN
-
urn:nbn:de:gbv:95-110521
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:42 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Granitzny, Anne
- Bibliothek der Tierärztlichen Hochschule Hannover
Entstanden
- 2017
Ähnliche Objekte (12)
Oral cladribine treatment and idiosyncratic drug-induced liver injury in multiple sclerosis
New approaches to improve prediction of drug-induced liver injury
Idiosyncratic drug-induced liver injury (DILI) and herb-induced liver injury (HILI): diagnostic algorithm based on the quantitative Roussel Uclaf Causality Assessment Method (RUCAM)
Molecular research on drug induced liver injury
The challenge of drug-induced liver injury (DILI)
Drug induced liver injury: do we still need a routine liver biopsy for diagnosis today?
RUCAM in drug and herb induced liver injury: the update
Charakterisierung der Chemikalien-induzierten Leberschädigung („Drug-Induced Liver Injury“ – DILI)
Drug induced liver injury: accuracy of diagnosis in published reports
Mechanism of liver cell injury by the cytostatic drug melphalan
Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations
Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations
Oral cladribine treatment and idiosyncratic drug-induced liver injury in multiple sclerosis
New approaches to improve prediction of drug-induced liver injury
Idiosyncratic drug-induced liver injury (DILI) and herb-induced liver injury (HILI): diagnostic algorithm based on the quantitative Roussel Uclaf Causality Assessment Method (RUCAM)
Molecular research on drug induced liver injury
The challenge of drug-induced liver injury (DILI)
Drug induced liver injury: do we still need a routine liver biopsy for diagnosis today?
RUCAM in drug and herb induced liver injury: the update
Charakterisierung der Chemikalien-induzierten Leberschädigung („Drug-Induced Liver Injury“ – DILI)
Drug induced liver injury: accuracy of diagnosis in published reports
Mechanism of liver cell injury by the cytostatic drug melphalan
Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations
Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations
Oral cladribine treatment and idiosyncratic drug-induced liver injury in multiple sclerosis
New approaches to improve prediction of drug-induced liver injury
Idiosyncratic drug-induced liver injury (DILI) and herb-induced liver injury (HILI): diagnostic algorithm based on the quantitative Roussel Uclaf Causality Assessment Method (RUCAM)
Molecular research on drug induced liver injury
The challenge of drug-induced liver injury (DILI)
Drug induced liver injury: do we still need a routine liver biopsy for diagnosis today?
RUCAM in drug and herb induced liver injury: the update
Charakterisierung der Chemikalien-induzierten Leberschädigung („Drug-Induced Liver Injury“ – DILI)
Drug induced liver injury: accuracy of diagnosis in published reports
Mechanism of liver cell injury by the cytostatic drug melphalan
Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations